https://orcid.org/0000-0003-4183-5533
Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Elena Pezzolo, Andrea Sechi, Jacopo Tartaglia & Luigi Naldi. (2023) A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults. Expert Review of Clinical Immunology 0:0, pages 1-12.
Read now
Read now
Eva Moennig & Stephan Traidl. (2022) Real-World Experience with Tralokinumab in a Patient with Recalcitrant Atopic Dermatitis: A Case Report. Clinical, Cosmetic and Investigational Dermatology 15, pages 2825-2830.
Read now
Read now
Andrea Chiricozzi, Niccolò Gori, Martina Maurelli, Paolo Gisondi, Giacomo Caldarola, Clara De Simone, Ketty Peris & Giampiero Girolomoni. (2022) Biological agents targeting interleukin-13 for atopic dermatitis. Expert Opinion on Biological Therapy 22:5, pages 651-659.
Read now
Read now
Giuseppe Ingrasci, Zoe M. Lipman & Gil Yosipovitch. (2021) When topical therapy of atopic dermatitis fails: a guide for the clinician. Expert Review of Clinical Immunology 17:12, pages 1245-1256.
Read now
Read now
Articles from other publishers (12)
Eric L. Simpson, Andrew E. Pink, Andrew Blauvelt, Melinda Gooderham, April W. Armstrong, Margitta Worm, Norito Katoh, Ketty Peris, Luis Puig, Sébastien Barbarot, Thomas Mark, Louise Abildgaard Steffensen, Ann-Marie Tindberg & Andreas Wollenberg. (2023) Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials. American Journal of Clinical Dermatology.
Crossref
Crossref
Diana Bernardo, Thomas Bieber & Tiago Torres. (2023) Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis. American Journal of Clinical Dermatology 24:5, pages 753-764.
Crossref
Crossref
Anne R Schlösser, Madena Shareef, Jill Olydam, Tamar E C Nijsten & Dirk Jan Hijnen. (2023) Tralokinumab treatment for patients with moderate-to-severe atopic dermatitis in daily practice. Clinical and Experimental Dermatology 48:5, pages 510-517.
Crossref
Crossref
Maddalena Napolitano, Francesca di Vico, Angelo Ruggiero, Gabriella Fabbrocini & Cataldo Patruno. (2023) The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis. Frontiers in Medicine 10.
Crossref
Crossref
Yuliya Lytvyn & Melinda Gooderham. (2023) Targeting Interleukin 13 for the Treatment of Atopic Dermatitis. Pharmaceutics 15:2, pages 568.
Crossref
Crossref
Rubén Fernández‐Santamaría, José Antonio Cañas & Carlos J. Aranda. (2022)
IL
‐13: An essential
cDC2s
partner to maintain skin homeostasis
. Allergy 77:9, pages 2869-2871.
Crossref
Crossref
Helena Iznardo & Luís Puig. (2022) IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications. International Journal of Molecular Sciences 23:16, pages 9479.
Crossref
Crossref
Pernille M. Hansen, Maxim A. X. Tollenaere, Anne Hedengran, Steffen Heegaard, Petra Amoudruz, Mads Røpke, Jacob P. Thyssen, Miriam Kolko & Hanne Norsgaard. (2022) IL‐4 and IL‐13 both contribute to the homeostasis of human conjunctival goblet cells in vitro. Allergy.
Crossref
Crossref
Sagar P. Bapat, Caroline Whitty, Cody T. Mowery, Yuqiong Liang, Arum Yoo, Zewen Jiang, Michael C. Peters, Ling-juan Zhang, Ian Vogel, Carmen Zhou, Vinh Q. Nguyen, Zhongmei Li, Christina Chang, Wandi S. Zhu, Annette T. Hastie, Helen He, Xin Ren, Wenli Qiu, Sarah G. Gayer, Chang Liu, Eun Jung Choi, Marlys Fassett, Jarish N. Cohen, Jamie L. Sturgill, Laura E. Crotty Alexander, Jae Myoung Suh, Christopher Liddle, Annette R. Atkins, Ruth T. Yu, Michael Downes, Sihao Liu, Barbara S. Nikolajczyk, In-Kyu Lee, Emma Guttman-Yassky, K. Mark Ansel, Prescott G. Woodruff, John V. Fahy, Dean Sheppard, Richard L. Gallo, Chun Jimmie Ye, Ronald M. Evans, Ye Zheng & Alexander Marson. (2022) Obesity alters pathology and treatment response in inflammatory disease. Nature 604:7905, pages 337-342.
Crossref
Crossref
Andreas Wollenberg, Stephan Weidinger, Margitta Worm & Thomas Bieber. (2021) Tralokinumab bei atopischer Dermatitis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19:10, pages 1435-1442.
Crossref
Crossref
Andreas Wollenberg, Stephan Weidinger, Margitta Worm & Thomas Bieber. (2021) Tralokinumab in atopic dermatitis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19:10, pages 1435-1442.
Crossref
Crossref
Simone Garcovich, Martina Maurelli, Paolo Gisondi, Ketty Peris, Gil Yosipovitch & Giampiero Girolomoni. (2021) Pruritus as a Distinctive Feature of Type 2 Inflammation. Vaccines 9:3, pages 303.
Crossref
Crossref